A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.
about
A practical approach to aid physician interpretation of clinically actionable predictive biomarker results in a multi-platform tumor profiling serviceReverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical UseImpact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine.Recent progress in protein profiling of clinical tissues for next-generation molecular diagnostics.Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.Metastatic Salivary Gland Tumors: A Single-Center Study Demonstrating the Feasibility and Potential Clinical Benefit of Molecular-Profiling-Guided Therapy.A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine.Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy.Reverse phase protein arrays: mapping the path towards personalized medicine.Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.Clinical Outcomes of Patients with Rare and Heavily Pretreated Solid Tumors Treated according to the Results of Tumor Molecular Profiling.Impact of molecular profiling on overall survival of patients with advanced ovarian cancer.Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies.Institutional implementation of clinical tumor profiling on an unselected cancer population.Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project.Subtyping of breast cancer using reverse phase protein arrays.Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.Dual-Color, Multiplex Analysis of Protein Microarrays for Precision Medicine.Harnessing the power of proteomics for identification of oncogenic, druggable signalling pathways in cancer.Signaling pathway profiling using reverse-phase protein array and its clinical applications.Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study.Innovations in Clinical Trial Design in the Era of Molecular Profiling.A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients.Knockdown of FUSE binding protein 1 enhances the sensitivity of epithelial ovarian cancer cells to carboplatin.Determining personalized treatment by gene expression profiling in metastatic breast carcinoma patients: a pilot study.Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer.
P2860
Q27853000-7516A317-D1AB-4B63-9291-B6C3BF84B053Q28083256-D1D436BD-EF64-4926-BC6E-6454C799DA65Q35560129-2E404C74-1DD2-49B7-ACF7-1BE71D5F6387Q35714211-BD9C302F-1350-42FE-AC32-F8089FDE71AFQ35725751-3033081F-BD89-4BC4-8BD4-02BC932D519EQ35902206-D0724180-7117-48A1-9751-D009539E43F4Q36095613-DDBFC104-3694-4AF4-B74D-A78F23429F81Q36186223-44276725-68CC-4321-B47B-AD8E9584BB0BQ36270508-33440D34-2D02-431F-9DB1-FE8DA844B850Q36391073-1DDC9FD9-AC9F-4F0A-BA08-A5FE92B2E743Q36519831-10DBDC75-2917-4A8B-9B6E-74831FD84FE8Q36843773-D011596B-CF5B-4B87-AAB9-0475CE11BF8BQ37150582-A766BEAC-7DF8-48D3-92DF-B6CCD2AAAB0AQ37190190-83A80DC6-6BD3-4067-B200-375745B4DFA8Q37225334-4CC64D87-90C8-469E-B27D-5169FC2650E6Q37417570-0EDA1E48-A002-4F8D-A09E-CC94E7B58FD5Q37422731-AFDAFAB4-DBA9-4807-81E8-10D6CB562C49Q38268585-37BBACE6-062E-4CA5-89FD-7D9CE990D0C4Q38818107-C69993B4-E4EC-49DD-B336-51381A3D15C3Q38966416-C79EED29-E027-40DB-B0E2-70B2DC8B88ACQ39175714-9BF4470F-1BB4-48C2-B0D0-46E1904D52EBQ39377837-3B4EC838-EB53-4E27-9F78-F2097253ECCCQ44239255-9D33D34E-EDD6-4F9C-A1F5-52163068CA7AQ45059047-EA3D546D-5234-4F30-AFE8-1D4EE8668A2DQ47110205-599BBB4B-58A1-48AD-B549-5CD494BCFA8FQ47158563-E045D79C-65CD-4E6E-8FD3-74C3AD03BBFAQ47437634-8EC32000-A48D-4AEC-8998-63D3FBC9AF04Q50915266-380891D6-0896-42B2-99A1-68398672ADBAQ53552603-BD34026F-2056-4B61-AF48-FE35A6F8CEB7
P2860
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A pilot study utilizing multi- ...... ated metastatic breast cancer.
@en
type
label
A pilot study utilizing multi- ...... ated metastatic breast cancer.
@en
prefLabel
A pilot study utilizing multi- ...... ated metastatic breast cancer.
@en
P2093
P2860
P1476
A pilot study utilizing multi- ...... ated metastatic breast cancer.
@en
P2093
Bryant Dunetz
Daniel D Von Hoff
David M Loesch
Emanuel F Petricoin
Gayle S Jameson
Jasgit Sachdev
Julia D Wulfkuhle
Kimberley A Reeder
Lance A Liotta
Manpreet K Chadha
P2860
P2888
P304
P356
10.1007/S10549-014-3117-1
P407
P577
2014-09-11T00:00:00Z
P6179
1003451080